Global Pharmaceutical Retail Market – Analysis By Type (Independent Retailers, Pharmacy Chain), Market Share, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, UK, India, China, Japan)
Executive Summary
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Pharmaceutical Retail Market. The report analyzes the pharmaceutical retail market by Distribution Channel – Online retail and Offline retail. The report further assesses the global pharmaceutical retail market by independent/standalone outlets and organized chains. The global pharmaceutical market report assesses the market by Region (North America, Europe, Asia Pacific and Rest of the world) and by Country (U.S., Canada, Germany, United Kingdom, India, China, Japan)
According to Azoth Analytics research report, “Global Pharmaceutical Retail Market – Analysis By Type (Independent Retailers, Pharmacy Chain), Market Share, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, UK, India, China, Japan)”, the global market is projected to display a robust growth represented by a CAGR of 4.94% during 2018 – 2023.
The segment of Stand Alone/Independent Pharmacy Retail witnessed growth at a noteworthy rate over the past few years due to the increasing consumer base coupled with rising healthcare expenditure. However, Organised retail pharmacy chains is expected to witness robust growth in the forecast period due to convenient services offered which includes same-day home delivery; patient charge accounts; immunizations; compounding; and durable medical goods, maintaining health record of patient, e-prescribing in the developed nations etc. During 2018-2023, Pharmaceutical Retails Market is anticipated to grow at an increased rate due to rising chronic diseases worldwide along with intense competition among the market players. Moreover, changing disease profiles, innovative marketing strategies, introduction of new business models and upsurge in the hospital based pharmacies and wellness stores has been anticipated to propel thrust in the sales of Pharmaceutical Retails in the future. Amongst the regions, North America accounts for the largest regional share in the global Pharmaceutical Retail market in 2018. Key factors driving the robust growth rate of North America region include rising healthcare expenditure, increasing cognizance about various respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), paradigm shift of consumers towards organized players which offer high quality drugs and medicines are driving the demand of Pharmaceutical Retails in the market.
The report titled “Global Pharmaceutical Retail Market – Analysis By Type (Independent Retailers, Pharmacy Chain), Market Share, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, UK, India, China, Japan)” has covered and analysed the potential of Global Pharmaceutical Retail Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Pharmaceutical Retail market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Pharmaceutical Retail Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
A comprehensive research report created through extensive primary research (inputs from industry experts, companies, stakeholders) and secondary research, the report aims to present the analysis of Global Pharmaceutical Retail Market. The report analyzes the pharmaceutical retail market by Distribution Channel – Online retail and Offline retail. The report further assesses the global pharmaceutical retail market by independent/standalone outlets and organized chains. The global pharmaceutical market report assesses the market by Region (North America, Europe, Asia Pacific and Rest of the world) and by Country (U.S., Canada, Germany, United Kingdom, India, China, Japan)
According to Azoth Analytics research report, “Global Pharmaceutical Retail Market – Analysis By Type (Independent Retailers, Pharmacy Chain), Market Share, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, UK, India, China, Japan)”, the global market is projected to display a robust growth represented by a CAGR of 4.94% during 2018 – 2023.
The segment of Stand Alone/Independent Pharmacy Retail witnessed growth at a noteworthy rate over the past few years due to the increasing consumer base coupled with rising healthcare expenditure. However, Organised retail pharmacy chains is expected to witness robust growth in the forecast period due to convenient services offered which includes same-day home delivery; patient charge accounts; immunizations; compounding; and durable medical goods, maintaining health record of patient, e-prescribing in the developed nations etc. During 2018-2023, Pharmaceutical Retails Market is anticipated to grow at an increased rate due to rising chronic diseases worldwide along with intense competition among the market players. Moreover, changing disease profiles, innovative marketing strategies, introduction of new business models and upsurge in the hospital based pharmacies and wellness stores has been anticipated to propel thrust in the sales of Pharmaceutical Retails in the future. Amongst the regions, North America accounts for the largest regional share in the global Pharmaceutical Retail market in 2018. Key factors driving the robust growth rate of North America region include rising healthcare expenditure, increasing cognizance about various respiratory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), paradigm shift of consumers towards organized players which offer high quality drugs and medicines are driving the demand of Pharmaceutical Retails in the market.
The report titled “Global Pharmaceutical Retail Market – Analysis By Type (Independent Retailers, Pharmacy Chain), Market Share, By Region, By Country: Opportunities and Forecasts (2018-2023) - By Region (N. America, Europe, APAC, ROW), By Country (U.S., Canada, Germany, UK, India, China, Japan)” has covered and analysed the potential of Global Pharmaceutical Retail Market and provides statistics and information on market size, shares and growth factors. The report intends to provide cutting-edge market intelligence and help decision makers take sound investment evaluation. Besides, the report also identifies and analyses the emerging trends along with major drivers, challenges and opportunities in the global Pharmaceutical Retail market. Additionally, the report also highlights market entry strategies for various companies across the globe.
Scope of the Report
Global Pharmaceutical Retail Market (Actual Period: 2013-2017, Forecast Period: 2018-2023)
- Pharmaceutical Retail Market – Sizing, Growth, Forecast
- Analysis By Distribution Channel – Online, Offline
- Analysis By Type – Independent/Stand Alone, Organized Chains, Others
- Pharmaceutical Retail Market – Sizing, Growth, Forecast
- Analysis By Distribution Channel – Online, Offline
- Analysis By Type – Independent/Stand Alone, Organized Chains, Others
- Pharmaceutical Retail Market – Sizing, Growth, Forecast
- Analysis By Distribution Channel – Online, Offline
- Analysis By Type – Independent/Stand Alone, Organized Chains, Others
- Market Dynamics – Drivers and Restraints
- Market Trends
- Porter Five Force Analysis
- Policy and Regulatory Landscape
- Company Analysis - CVS Health, Walgreens Boots Alliance, Albertsons, Rossmann, Rite Aid, Jean Coutu, Nepstar
The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.
1. RESEARCH METHODOLOGY
2. EXECUTIVE SUMMARY
3. STRATEGIC RECOMMENDATIONS
4. PHARMACEUTICAL RETAIL OUTLOOK
5. GLOBAL PHARMACEUTICAL RETAIL MARKET: GROWTH AND FORECAST
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
6. GLOBAL PHARMACEUTICAL RETAIL MARKET: SEGMENT ANALYSIS
6.1 Global Pharmaceutical Retail Market Size, By Distribution Channel: Breakdown (%)
6.1.1 Global Pharmaceutical Retail Market Size, By Distribution Channel, 2017 (%)
6.1.2 Global Pharmaceutical Retail Market Size, By Distribution Channel, 2023 (%)
6.2 Global Pharmaceutical Online Retail Market, By Value (2013-2023)
6.3 Global Pharmaceutical offline Retail Market, By Value (2013-2023)
6.4 Global Pharmaceutical Retail Market Size, By Type: Breakdown (%)
6.4.1 Global Pharmaceutical Retail Market Size, By Type, 2017 (%)
6.4.2 Global Pharmaceutical Retail Market Size, By Type, 2023 (%)
6.5 Global Independent pharmacy Pharmaceutical Retail Market, By Value (2013-2023)
6.6 Global Organised Chain Pharmaceutical Retail Market, By Value (2013-2023)
6.7 Global Others Pharmaceutical Retail Market, By Value (2013-2023)
7. GLOBAL PHARMACEUTICAL RETAIL MARKET: REGIONAL ANALYSIS
7.1 Global Pharmaceutical Retail Market Size, By Region: Breakdown (%)
7.1.1 Global Pharmaceutical Retail Market Size, By Region, 2017 (%)
7.1.2 Global Pharmaceutical Retail Market Size, By Region, 2023 (%)
7.2 North America Pharmaceutical Retail Market: Growth and Forecast
7.2.1 By Value (2013-2017)
7.2.2 By Value (2018-2023)
7.3 North America Pharmaceutical Retail Market Size, By Type
7.3.1 By Value (2013-2017)
7.3.2 By Value (2018-2023)
7.4 North America Pharmaceutical Retail Market: Country Analysis (U.S and Canada)
7.4.1 U.S Pharmaceutical Retail Market, By Value (2013-2023)
7.4.2 U.S Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.4.3 Canada Pharmaceutical Retail Market, By Value (2013-2023)
7.4.4 Canada Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.5 Europe Pharmaceutical Retail Market: Growth and Forecast
7.5.1 By Value (2013-2017)
7.5.2 By Value (2018-2023)
7.6 Europe Pharmaceutical Retail Market Size, By Type
7.6.1 By Type, By Value (2013-2023)
7.6.2 By Type, By Value (2013-2023)
7.7 Europe Pharmaceutical Retail Market: Country Analysis (U.K and Germany)
7.7.1 U.K Pharmaceutical Retail Market, By Value (2013-2023)
7.7.2 U.K Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.7.3 Germany Pharmaceutical Retail Market, By Value (2013-2023)
7.7.4 Germany Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.8 APAC Pharmaceutical Retail Market: Growth and Forecast
7.8.1 By Value (2013-2017)
7.8.2 By Value (2018-2023)
7.9 APAC Pharmaceutical Retail Market Size, By Type
7.9.1 By Type, By Value (2013-2027)
7.9.2 By Type, By Value (2018-2023)
7.10 APAC Pharmaceutical Retail Market: Country Analysis (India, China and Japan)
7.10.1 India Pharmaceutical Retail Market, By Value (2013-2023)
7.10.2 India Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.10.3 China Pharmaceutical Retail Market, By Value (2013-2023)
7.10.4 China Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.10.5 Japan Pharmaceutical Retail Market, By Value (2013-2023)
7.10.6 Japan Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.11 ROW Pharmaceutical Retail Market: Growth and Forecast
7.11.1 By Value (2013-2023)
7.11.2 By Type, By Value (2013-2017)
7.11.3 By Type, By Value (2018-2023)
8. GLOBAL PHARMACEUTICAL RETAIL MARKET DYNAMICS
8.1 Global Pharmaceutical Retail Market Drivers
8.2 Global Pharmaceutical Retail Market Restraints
9. GLOBAL PHARMACEUTICAL RETAIL MARKET TRENDS
10. PORTER FIVE FORCE ANALYSIS
11. SWOT ANALYSIS
12. COMPANY PROFILES
12.1 CVS Health
12.2 Walgreens Boots Alliance Inc.
12.3 Albertsons
12.4 Rossmann
12.5 Rite Aid
12.6 Jean Coutu
12.7 Nepstar
2. EXECUTIVE SUMMARY
3. STRATEGIC RECOMMENDATIONS
4. PHARMACEUTICAL RETAIL OUTLOOK
5. GLOBAL PHARMACEUTICAL RETAIL MARKET: GROWTH AND FORECAST
5.1 By Value (2013-2017)
5.2 By Value (2018-2023)
6. GLOBAL PHARMACEUTICAL RETAIL MARKET: SEGMENT ANALYSIS
6.1 Global Pharmaceutical Retail Market Size, By Distribution Channel: Breakdown (%)
6.1.1 Global Pharmaceutical Retail Market Size, By Distribution Channel, 2017 (%)
6.1.2 Global Pharmaceutical Retail Market Size, By Distribution Channel, 2023 (%)
6.2 Global Pharmaceutical Online Retail Market, By Value (2013-2023)
6.3 Global Pharmaceutical offline Retail Market, By Value (2013-2023)
6.4 Global Pharmaceutical Retail Market Size, By Type: Breakdown (%)
6.4.1 Global Pharmaceutical Retail Market Size, By Type, 2017 (%)
6.4.2 Global Pharmaceutical Retail Market Size, By Type, 2023 (%)
6.5 Global Independent pharmacy Pharmaceutical Retail Market, By Value (2013-2023)
6.6 Global Organised Chain Pharmaceutical Retail Market, By Value (2013-2023)
6.7 Global Others Pharmaceutical Retail Market, By Value (2013-2023)
7. GLOBAL PHARMACEUTICAL RETAIL MARKET: REGIONAL ANALYSIS
7.1 Global Pharmaceutical Retail Market Size, By Region: Breakdown (%)
7.1.1 Global Pharmaceutical Retail Market Size, By Region, 2017 (%)
7.1.2 Global Pharmaceutical Retail Market Size, By Region, 2023 (%)
7.2 North America Pharmaceutical Retail Market: Growth and Forecast
7.2.1 By Value (2013-2017)
7.2.2 By Value (2018-2023)
7.3 North America Pharmaceutical Retail Market Size, By Type
7.3.1 By Value (2013-2017)
7.3.2 By Value (2018-2023)
7.4 North America Pharmaceutical Retail Market: Country Analysis (U.S and Canada)
7.4.1 U.S Pharmaceutical Retail Market, By Value (2013-2023)
7.4.2 U.S Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.4.3 Canada Pharmaceutical Retail Market, By Value (2013-2023)
7.4.4 Canada Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.5 Europe Pharmaceutical Retail Market: Growth and Forecast
7.5.1 By Value (2013-2017)
7.5.2 By Value (2018-2023)
7.6 Europe Pharmaceutical Retail Market Size, By Type
7.6.1 By Type, By Value (2013-2023)
7.6.2 By Type, By Value (2013-2023)
7.7 Europe Pharmaceutical Retail Market: Country Analysis (U.K and Germany)
7.7.1 U.K Pharmaceutical Retail Market, By Value (2013-2023)
7.7.2 U.K Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.7.3 Germany Pharmaceutical Retail Market, By Value (2013-2023)
7.7.4 Germany Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.8 APAC Pharmaceutical Retail Market: Growth and Forecast
7.8.1 By Value (2013-2017)
7.8.2 By Value (2018-2023)
7.9 APAC Pharmaceutical Retail Market Size, By Type
7.9.1 By Type, By Value (2013-2027)
7.9.2 By Type, By Value (2018-2023)
7.10 APAC Pharmaceutical Retail Market: Country Analysis (India, China and Japan)
7.10.1 India Pharmaceutical Retail Market, By Value (2013-2023)
7.10.2 India Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.10.3 China Pharmaceutical Retail Market, By Value (2013-2023)
7.10.4 China Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.10.5 Japan Pharmaceutical Retail Market, By Value (2013-2023)
7.10.6 Japan Pharmaceutical Retail Market, By Type, By Value (2013-2023)
7.11 ROW Pharmaceutical Retail Market: Growth and Forecast
7.11.1 By Value (2013-2023)
7.11.2 By Type, By Value (2013-2017)
7.11.3 By Type, By Value (2018-2023)
8. GLOBAL PHARMACEUTICAL RETAIL MARKET DYNAMICS
8.1 Global Pharmaceutical Retail Market Drivers
8.2 Global Pharmaceutical Retail Market Restraints
9. GLOBAL PHARMACEUTICAL RETAIL MARKET TRENDS
10. PORTER FIVE FORCE ANALYSIS
11. SWOT ANALYSIS
12. COMPANY PROFILES
12.1 CVS Health
12.2 Walgreens Boots Alliance Inc.
12.3 Albertsons
12.4 Rossmann
12.5 Rite Aid
12.6 Jean Coutu
12.7 Nepstar
LIST OF FIGURES
Figure 1: Global Pharmaceutical Retail Market Size, By Value, 2013-2017 (USD Billion)
Figure 2: Global Pharmaceutical Retail Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 3: Average price mark up of medicines in emerging markets at each stage of supply chain Post manufacturing range from 10%-75%
Figure 4: Distributions of persons aged 60 years or above by region in millions, 2015 and 2030F
Figure 5: Population ages 65 and above, By Select Region, 2013-2017 (% of total)
Figure 6: Projected global population aged 60 years & above (In Billions)
Figure 7: Projected global population (In Billions)
Figure 8: World Life expectancy at birth for selected periods
Figure 9: Life expectancy at birth for selected periods, By Region
Figure 10: Projected medicine spending distribution, By Regions 2020
Figure 11: Obese Population, By Country, 2017 (In Millions)
Figure 12: Global Diabetic Adult Population, 2017 & 2045 (In %)
Figure 13: Healthcare Expenditure (Share of GDP), By Select Country, 2012-2016 (In %)
Figure 14: Global Pharmaceutical Retail Market Size, By Product Type, 2017 (%)
Figure 15: Global Pharmaceutical Retail Market Size, By Product Type, 2023 (%)
Figure 16: Global Online Pharmaceutical Retail Market, By Value, 2013-2017 (USD Billion)
Figure 17: Global Online Pharmaceutical Retail Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 18: Global Offline Pharmaceutical Retail Market , By Value, 2013-2017 (USD Billion)
Figure 19: Global Offline Pharmaceutical Retail Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 20: Global Pharmaceutical Retail Market Size, By Package Type, 2017 (%)
Figure 21: Global Pharmaceutical Retail Market Size, By Package Type, 2023 (%)
Figure 22: Global Independent pharmacy Pharmaceutical Retail Market , By Value, 2013-2017 (USD Billion)
Figure 23: Global Independent pharmacy Pharmaceutical Retail Market,By Value, Forecast, 2018-2023(USD Billion)
Figure 24: Global Organized Chain Pharmaceutical Market, By Value, 2013-2017 (USD Billion)
Figure 25: Global Organized Chain Pharmaceutical Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 26: Global Others Pharmaceutical Market, By Value, 2013-2017 (USD Billion)
Figure 27: Global Others Pharmaceutical Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 28: Global Pharmaceutical Retail Market Size, By Region, 2017 (%)
Figure 29: Global Pharmaceutical Retail Market Size, By Region, 2023 (%)
Figure 30: North America Pharmaceutical Retail Market Size, By Value, 2013-2017 (USD Billion)
Figure 31: North America Pharmaceutical Retail Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 32: North America Healthcare Cost Per Capita, 2016 (USD)
Figure 33: North America Population Ages 65 and above, 2012-2016 (% of Total)
Figure 34: North America GDP, 2012-2016 (USD Trillion)
Figure 35: North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 36: North America DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 37: North America DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 38: North America DALYs of COPD (2013-2016 %)
Figure 39: North America DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 40: North America DALYs of Diabetes (2013-2016, %)
Figure 41: Savings from Generics in U.S Healthcare System, 2012-2016 (USD Billion)
Figure 42: Savings from U.S Healthcare System, By Leading Diseases, 2016 (USD Billion)
Figure 43: North America Pharmaceutical Retail Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 44: North America Pharmaceutical Retail Market: By Product Type, By Value, 2018-2023 (USD Billion)
Figure 45: U.S. Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 46: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD)
Figure 47: United States, Market Share of Leading Organized Pharmacy Chains (Revenues 2016)
Figure 48: Share of Leading companies in Metro areas
Figure 49: Projected US Population over age 85 (in millions)
Figure 50: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD)
Figure 51: Pharmacy Industry Prescription Revenues (USD Billions)
Figure 52: U.S., Prescription Drugs Market share, By Pharmacies 2017
Figure 53: U.S., Population ages 65 and above, 2013-2016 (% of total)
Figure 54: U.S., Population ages 65 and above, Forecast (In Millions)
Figure 55: United States DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 56: United States DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 57: United States DALYs of COPD (2013-2016, %)
Figure 58: United States DALYs of Alzheimer Disease and Other Dementias (2013-2016 %)
Figure 59: United States DALYs of Diabetes Mellitus (2013-2016 %)
Figure 60: Utilization of E-Prescribing, 2013-2017 ( in Billions )
Figure 61: United States, Nominal Spending on Medicines, 2013-2016 (USD Billions)
Figure 62: United States, Medicine Invoice and Net Spending, 2013-2017(USD Billion)
Figure 63: United States, Real Net Per Capita Medicine Spending and Growth, 2013-2017 (USD)
Figure 64: U.S Pharmaceutical Retail Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 65: Independent Pharmacy, By Social Media
Figure 66: Canada Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 67: Canada, Market Share of Leading Organized Pharmacy Chains (Number of outlets in 2017)
Figure 68: Canada, Growth of retail prescriptions, 2013-2017 (%)
Figure 69: Leading Store chains in Canada, 2016
Figure 70: Canada, Expenditure on Health as a share of GDP, 2012-2016 (in %)
Figure 71: Canada, Per Capita Healthcare Expenditure, 2012-2016 (USD)
Figure 72: Canada, Population ages 65 and above, 2012-2016 (% of total)
Figure 73: Canada DALYs of Ischemic Heart Disease (2013-2016 %)
Figure 74: Canada DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 75: Canada DALYs of COPD (2013-2016, %)
Figure 76: Canada DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 77: Canada DALYs of Diabetes (2013-2016, %)
Figure 78: Canada Pharmaceutical Retail Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 79: Canada Retail Pharmacies, By Outlet Type 2013-2017
Figure 80: Major Players in Pharmaceutical Retail Market in North America
Figure 81: Europe Pharmaceutical Retail Market Size, By Value, 2013-2017 (USD Billion)
Figure 82: Europe Pharmaceutical Retail Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 83: % of Pharmacies in Virtual Retail Chains Pharmacy in Europe, by countries
Figure 84: Per Capita Health Expenditure, By Select Country, 2016 (USD)
Figure 85: European Union, Population ages 65 and above, 2013-2017 (% of total)
Figure 86: European Country Population Aged 65 and Above, 2012-2016 (% of Total)
Figure 87: Share of Generics in Pharmaceutical Market Sales, By Volume (Ex-Factory Prices)
Figure 88: Western Europe DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 89: Western Europe DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 90: Western Europe DALYs of COPD (2013-2016, %)
Figure 91: Western Europe DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 92: Western Europe DALYs of Diabetes (2013-2016 %)
Figure 93: Breakdown of Total Health Expenditure in Europe (%)
Figure 94: Europe Pharmaceutical Retail Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 95: Europe Pharmaceutical Retail Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 96: Number of Pharmacies in Europe 2016
Figure 97: U.K Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 98: United Kingdom, Market Share of Leading Organized Pharmacy Chains (Number of Retail Outlets 2017)
Figure 99: United Kingdom Pharmaceutical Consumption, Daily Dosage per 1000 inhabitants per day
Figure 100: U.K. Pharmaceutical Retail Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 101: United Kingdom, Number of Community Pharmacies
Figure 102: United Kingdom, Number of Internet Pharmacies, 2013-2016
Figure 103: U.K, Per Capita Health Expenditure, 2013-2017 (USD)
Figure 104: U.K, Health Expenditure, Share of GDP, 2013-2017 (In %)
Figure 105: United Kingdom DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 106: United Kingdom DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 107: United Kingdom DALYs of COPD (2013-2016 %)
Figure 108: United Kingdom DALYs of Alzheimer Disease and Other Dementias (2013-2016 %)
Figure 109: United Kingdom DALYs of Diabetes (2013-2016, %)
Figure 110: Germany Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 111: Germany, Market Share of Leading Organized Pharmacy Chains (Number of outlets in 2017)
Figure 112: Germany, Type of pharmacies
Figure 113: Germany, Population ages 65 and above, 2012-2016 (% total)
Figure 114: Germany, Per Capita Health Expenditure, 2013-2017 (USD
Figure 115: Germany, Health Expenditure, Share of GDP, 2013-2017 (In %)
Figure 116: Germany DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 117: Germany DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 118: Germany DALYs of COPD (2013-2016,%)
Figure 119: Germany DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 120: Germany DALYs of Diabetes (2013-2016, %)
Figure 121: Germany, Yearly vale of exported pharmaceuticals, 2012-2016 (In Billion Euro)
Figure 122: Germany, Population ages 65 and above, 2012-2016 (% total)
Figure 123: Germany Pharmaceutical Retail Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 124: Germany, Number of Individual Pharmacies 2014-2016
Figure 125: Germany, Number of Branch Pharmacies, 2014-2016
Figure 126: APAC Pharmaceutical Retail Market Size, By Value, 2013-2017 (USD Billion)
Figure 127: APAC Pharmaceutical Retail Market Size, By Value, Forecast, 2018-2023(USD Billion)
Figure 128: Population ages 65 and above, APAC Region, By Select Countries, 2016 (% of total)
Figure 129: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
Figure 130: South East Asia, East Asia, Oceania , DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 131: South East Asia, East Asia, Oceania DALYs of Chronic Kidney Disease(2013-2016, %)
Figure 132: South East Asia, East Asia, Oceania DALYs of COPD (2013-2016, %)
Figure 133: South East Asia, Oceania, DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 134: South East Asia, East Asia, Oceania DALYs of Diabetes (2013-2016, %)
Figure 135: APAC Pharmaceutical Retail Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 136: APAC Pharmaceutical Retail Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 137: India Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 138: India DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 139: India DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 140: India DALYs of COPD (2013-2016, %)
Figure 141: India DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 142: India DALYs of Diabetes (2013-2016 %)
Figure 143: India, Market Share of Leading Organized Pharmacy Chains (Number of Outlets in 2017)
Figure 144: India Pharmaceutical Retail
Figure 145: India Revenue share of Indian Pharmaceutical sub segments 2015 (%)
Figure 146: Indian Pharmaceutical Revenues (USD Billion)
Figure 147: Supply chain of medicines in India
Figure 148: Frequency of buying medicines in India , By Age
Figure 149: Sources to buy Medicines in India, By Age
Figure 150: India, Total Population, 2012-2022F (In Billion)
Figure 151: India Pharmaceutical Retail Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 152: China Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 153: China, Market Share of Leading Organized Pharmacy Chains (Number of outlets in 2017)
Figure 154: Number of pharmacists in China, 2016
Figure 155: China, Population ages 65 and above, 2012-2016 (% of total)
Figure 156: China Healthcare Expenditure Outlook (%)
Figure 157: China, GDP Growth Per Year, 2015-2019 (In %)
Figure 158: China, Total Population, 2012-2022F (In Billion)
Figure 159: China DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 160: China DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 161: China DALYs of COPD (2013-2016, %)
Figure 162: China DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 163: China DALYs of Diabetes (2013-2016, %)
Figure 164: China Pharmaceutical Retail Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 165: Japan Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 166: Japan Market Share of Leading Organized Pharmacy Chains (Number of outlets in 2017)
Figure 167: Japan Pharmaceutical Retail Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 168: ROW Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 169: ROW Pharmaceutical Retail Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 170: ROW Pharmaceutical Retail Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 171: CVS Health Corporation, Sales Revenue, 2013-2017 (USD Billion)
Figure 172: CVS Health Corporation, Number of stores that operates a pharmacy , 2013-2017
Figure 173: Walgreens Retail Pharmacy International Sales Revenue, 2015-2017 (USD Billion)
Figure 174: Walgreens Retail Pharmacy US, Sales, By Business Sector, 2017 (%)
Figure 175: Retail Pharmacy USA, By states 2017
Figure 176: Retail Pharmacy International, By states 2017
Figure 1: Global Pharmaceutical Retail Market Size, By Value, 2013-2017 (USD Billion)
Figure 2: Global Pharmaceutical Retail Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 3: Average price mark up of medicines in emerging markets at each stage of supply chain Post manufacturing range from 10%-75%
Figure 4: Distributions of persons aged 60 years or above by region in millions, 2015 and 2030F
Figure 5: Population ages 65 and above, By Select Region, 2013-2017 (% of total)
Figure 6: Projected global population aged 60 years & above (In Billions)
Figure 7: Projected global population (In Billions)
Figure 8: World Life expectancy at birth for selected periods
Figure 9: Life expectancy at birth for selected periods, By Region
Figure 10: Projected medicine spending distribution, By Regions 2020
Figure 11: Obese Population, By Country, 2017 (In Millions)
Figure 12: Global Diabetic Adult Population, 2017 & 2045 (In %)
Figure 13: Healthcare Expenditure (Share of GDP), By Select Country, 2012-2016 (In %)
Figure 14: Global Pharmaceutical Retail Market Size, By Product Type, 2017 (%)
Figure 15: Global Pharmaceutical Retail Market Size, By Product Type, 2023 (%)
Figure 16: Global Online Pharmaceutical Retail Market, By Value, 2013-2017 (USD Billion)
Figure 17: Global Online Pharmaceutical Retail Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 18: Global Offline Pharmaceutical Retail Market , By Value, 2013-2017 (USD Billion)
Figure 19: Global Offline Pharmaceutical Retail Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 20: Global Pharmaceutical Retail Market Size, By Package Type, 2017 (%)
Figure 21: Global Pharmaceutical Retail Market Size, By Package Type, 2023 (%)
Figure 22: Global Independent pharmacy Pharmaceutical Retail Market , By Value, 2013-2017 (USD Billion)
Figure 23: Global Independent pharmacy Pharmaceutical Retail Market,By Value, Forecast, 2018-2023(USD Billion)
Figure 24: Global Organized Chain Pharmaceutical Market, By Value, 2013-2017 (USD Billion)
Figure 25: Global Organized Chain Pharmaceutical Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 26: Global Others Pharmaceutical Market, By Value, 2013-2017 (USD Billion)
Figure 27: Global Others Pharmaceutical Market, By Value, Forecast, 2018-2023(USD Billion)
Figure 28: Global Pharmaceutical Retail Market Size, By Region, 2017 (%)
Figure 29: Global Pharmaceutical Retail Market Size, By Region, 2023 (%)
Figure 30: North America Pharmaceutical Retail Market Size, By Value, 2013-2017 (USD Billion)
Figure 31: North America Pharmaceutical Retail Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 32: North America Healthcare Cost Per Capita, 2016 (USD)
Figure 33: North America Population Ages 65 and above, 2012-2016 (% of Total)
Figure 34: North America GDP, 2012-2016 (USD Trillion)
Figure 35: North America GDP per capita, current prices, 2013-2023F (In USD)
Figure 36: North America DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 37: North America DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 38: North America DALYs of COPD (2013-2016 %)
Figure 39: North America DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 40: North America DALYs of Diabetes (2013-2016, %)
Figure 41: Savings from Generics in U.S Healthcare System, 2012-2016 (USD Billion)
Figure 42: Savings from U.S Healthcare System, By Leading Diseases, 2016 (USD Billion)
Figure 43: North America Pharmaceutical Retail Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 44: North America Pharmaceutical Retail Market: By Product Type, By Value, 2018-2023 (USD Billion)
Figure 45: U.S. Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 46: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD)
Figure 47: United States, Market Share of Leading Organized Pharmacy Chains (Revenues 2016)
Figure 48: Share of Leading companies in Metro areas
Figure 49: Projected US Population over age 85 (in millions)
Figure 50: U.S., Per Capita Expenditure on Healthcare, 2012-2018E (In USD)
Figure 51: Pharmacy Industry Prescription Revenues (USD Billions)
Figure 52: U.S., Prescription Drugs Market share, By Pharmacies 2017
Figure 53: U.S., Population ages 65 and above, 2013-2016 (% of total)
Figure 54: U.S., Population ages 65 and above, Forecast (In Millions)
Figure 55: United States DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 56: United States DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 57: United States DALYs of COPD (2013-2016, %)
Figure 58: United States DALYs of Alzheimer Disease and Other Dementias (2013-2016 %)
Figure 59: United States DALYs of Diabetes Mellitus (2013-2016 %)
Figure 60: Utilization of E-Prescribing, 2013-2017 ( in Billions )
Figure 61: United States, Nominal Spending on Medicines, 2013-2016 (USD Billions)
Figure 62: United States, Medicine Invoice and Net Spending, 2013-2017(USD Billion)
Figure 63: United States, Real Net Per Capita Medicine Spending and Growth, 2013-2017 (USD)
Figure 64: U.S Pharmaceutical Retail Market: By Product Type, By Value, 2013-2023 (USD Billion)
Figure 65: Independent Pharmacy, By Social Media
Figure 66: Canada Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 67: Canada, Market Share of Leading Organized Pharmacy Chains (Number of outlets in 2017)
Figure 68: Canada, Growth of retail prescriptions, 2013-2017 (%)
Figure 69: Leading Store chains in Canada, 2016
Figure 70: Canada, Expenditure on Health as a share of GDP, 2012-2016 (in %)
Figure 71: Canada, Per Capita Healthcare Expenditure, 2012-2016 (USD)
Figure 72: Canada, Population ages 65 and above, 2012-2016 (% of total)
Figure 73: Canada DALYs of Ischemic Heart Disease (2013-2016 %)
Figure 74: Canada DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 75: Canada DALYs of COPD (2013-2016, %)
Figure 76: Canada DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 77: Canada DALYs of Diabetes (2013-2016, %)
Figure 78: Canada Pharmaceutical Retail Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 79: Canada Retail Pharmacies, By Outlet Type 2013-2017
Figure 80: Major Players in Pharmaceutical Retail Market in North America
Figure 81: Europe Pharmaceutical Retail Market Size, By Value, 2013-2017 (USD Billion)
Figure 82: Europe Pharmaceutical Retail Market Size, By Value, Forecast, 2018-2023 (USD Billion)
Figure 83: % of Pharmacies in Virtual Retail Chains Pharmacy in Europe, by countries
Figure 84: Per Capita Health Expenditure, By Select Country, 2016 (USD)
Figure 85: European Union, Population ages 65 and above, 2013-2017 (% of total)
Figure 86: European Country Population Aged 65 and Above, 2012-2016 (% of Total)
Figure 87: Share of Generics in Pharmaceutical Market Sales, By Volume (Ex-Factory Prices)
Figure 88: Western Europe DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 89: Western Europe DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 90: Western Europe DALYs of COPD (2013-2016, %)
Figure 91: Western Europe DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 92: Western Europe DALYs of Diabetes (2013-2016 %)
Figure 93: Breakdown of Total Health Expenditure in Europe (%)
Figure 94: Europe Pharmaceutical Retail Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 95: Europe Pharmaceutical Retail Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 96: Number of Pharmacies in Europe 2016
Figure 97: U.K Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 98: United Kingdom, Market Share of Leading Organized Pharmacy Chains (Number of Retail Outlets 2017)
Figure 99: United Kingdom Pharmaceutical Consumption, Daily Dosage per 1000 inhabitants per day
Figure 100: U.K. Pharmaceutical Retail Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 101: United Kingdom, Number of Community Pharmacies
Figure 102: United Kingdom, Number of Internet Pharmacies, 2013-2016
Figure 103: U.K, Per Capita Health Expenditure, 2013-2017 (USD)
Figure 104: U.K, Health Expenditure, Share of GDP, 2013-2017 (In %)
Figure 105: United Kingdom DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 106: United Kingdom DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 107: United Kingdom DALYs of COPD (2013-2016 %)
Figure 108: United Kingdom DALYs of Alzheimer Disease and Other Dementias (2013-2016 %)
Figure 109: United Kingdom DALYs of Diabetes (2013-2016, %)
Figure 110: Germany Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 111: Germany, Market Share of Leading Organized Pharmacy Chains (Number of outlets in 2017)
Figure 112: Germany, Type of pharmacies
Figure 113: Germany, Population ages 65 and above, 2012-2016 (% total)
Figure 114: Germany, Per Capita Health Expenditure, 2013-2017 (USD
Figure 115: Germany, Health Expenditure, Share of GDP, 2013-2017 (In %)
Figure 116: Germany DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 117: Germany DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 118: Germany DALYs of COPD (2013-2016,%)
Figure 119: Germany DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 120: Germany DALYs of Diabetes (2013-2016, %)
Figure 121: Germany, Yearly vale of exported pharmaceuticals, 2012-2016 (In Billion Euro)
Figure 122: Germany, Population ages 65 and above, 2012-2016 (% total)
Figure 123: Germany Pharmaceutical Retail Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 124: Germany, Number of Individual Pharmacies 2014-2016
Figure 125: Germany, Number of Branch Pharmacies, 2014-2016
Figure 126: APAC Pharmaceutical Retail Market Size, By Value, 2013-2017 (USD Billion)
Figure 127: APAC Pharmaceutical Retail Market Size, By Value, Forecast, 2018-2023(USD Billion)
Figure 128: Population ages 65 and above, APAC Region, By Select Countries, 2016 (% of total)
Figure 129: Population ages 65 and above, APAC Region, By Select Countries, 2050 (% of total)
Figure 130: South East Asia, East Asia, Oceania , DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 131: South East Asia, East Asia, Oceania DALYs of Chronic Kidney Disease(2013-2016, %)
Figure 132: South East Asia, East Asia, Oceania DALYs of COPD (2013-2016, %)
Figure 133: South East Asia, Oceania, DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 134: South East Asia, East Asia, Oceania DALYs of Diabetes (2013-2016, %)
Figure 135: APAC Pharmaceutical Retail Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 136: APAC Pharmaceutical Retail Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 137: India Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 138: India DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 139: India DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 140: India DALYs of COPD (2013-2016, %)
Figure 141: India DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 142: India DALYs of Diabetes (2013-2016 %)
Figure 143: India, Market Share of Leading Organized Pharmacy Chains (Number of Outlets in 2017)
Figure 144: India Pharmaceutical Retail
Figure 145: India Revenue share of Indian Pharmaceutical sub segments 2015 (%)
Figure 146: Indian Pharmaceutical Revenues (USD Billion)
Figure 147: Supply chain of medicines in India
Figure 148: Frequency of buying medicines in India , By Age
Figure 149: Sources to buy Medicines in India, By Age
Figure 150: India, Total Population, 2012-2022F (In Billion)
Figure 151: India Pharmaceutical Retail Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 152: China Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 153: China, Market Share of Leading Organized Pharmacy Chains (Number of outlets in 2017)
Figure 154: Number of pharmacists in China, 2016
Figure 155: China, Population ages 65 and above, 2012-2016 (% of total)
Figure 156: China Healthcare Expenditure Outlook (%)
Figure 157: China, GDP Growth Per Year, 2015-2019 (In %)
Figure 158: China, Total Population, 2012-2022F (In Billion)
Figure 159: China DALYs of Ischemic Heart Disease (2013-2016, %)
Figure 160: China DALYs of Chronic Kidney Disease (2013-2016, %)
Figure 161: China DALYs of COPD (2013-2016, %)
Figure 162: China DALYs of Alzheimer Disease and Other Dementias (2013-2016, %)
Figure 163: China DALYs of Diabetes (2013-2016, %)
Figure 164: China Pharmaceutical Retail Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 165: Japan Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 166: Japan Market Share of Leading Organized Pharmacy Chains (Number of outlets in 2017)
Figure 167: Japan Pharmaceutical Retail Market: By Type, By Value, 2013-2023 (USD Billion)
Figure 168: ROW Pharmaceutical Retail Market Size, By Value, 2013-2023 (USD Billion)
Figure 169: ROW Pharmaceutical Retail Market: By Type, By Value, 2013-2017 (USD Billion)
Figure 170: ROW Pharmaceutical Retail Market: By Type, By Value, 2018-2023 (USD Billion)
Figure 171: CVS Health Corporation, Sales Revenue, 2013-2017 (USD Billion)
Figure 172: CVS Health Corporation, Number of stores that operates a pharmacy , 2013-2017
Figure 173: Walgreens Retail Pharmacy International Sales Revenue, 2015-2017 (USD Billion)
Figure 174: Walgreens Retail Pharmacy US, Sales, By Business Sector, 2017 (%)
Figure 175: Retail Pharmacy USA, By states 2017
Figure 176: Retail Pharmacy International, By states 2017
LIST OF TABLES
Table 1: List of Abbreviations
Table 2: Recent Company Acquisitions in Pharmaceutical Retail Market
Table 3: U.S., Number of Retail Stores, By Companies 2016
Table 4: U.S., Total Pharmacies By Type 2013-2015
Table 5: U.S., Availability of Pharmacies 2015
Table 6: Advances Services by Community Pharmacies
Table 7: Germany, Number of Community Pharmacies, By State 2016
Table 1: List of Abbreviations
Table 2: Recent Company Acquisitions in Pharmaceutical Retail Market
Table 3: U.S., Number of Retail Stores, By Companies 2016
Table 4: U.S., Total Pharmacies By Type 2013-2015
Table 5: U.S., Availability of Pharmacies 2015
Table 6: Advances Services by Community Pharmacies
Table 7: Germany, Number of Community Pharmacies, By State 2016
